Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-22

Clinical Trial Update: A Study in Healthy Men to Test How BI 1595043 is Taken up in the Body When Given With or Without Food [Phase 1]

View source ↗

Summary

Phase 1 study in healthy men evaluating how BI 1595043 is absorbed when taken with versus without food; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BI 1595043

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Healthy | Phase 1 | Status: COMPLETED | Results posted: 2024-02-22